Basic Sciences Course at
CPSP Regional Centre, Lahore

LAHORE: The 87th Basic Medical Sciences Course has started at CPSP Regional Center Lahore, under the supervision of Prof. Rakhshanda Rehman, Dean, Medical Education, coordinated by Prof. Aley Hasan Zaidi.
This course is being attended by more than two hundred candidates of FCPS-I across the country. Prof. Rakhshanda Rehman, Vice President, CPSP speaking at the occasion said that this course has been organized according to the need of FCPS-I examination. The course will have lectures on Physiology, Haematology, Gynaecology, Microbiology, Biochemistry, Pathology, Anatomy, Histology, and Pharmacology in addition to other special lectures. The faculty for the course consists of Prof. Hamid Javed Qureshi, Prof. Muhammad Irfan Ashraf, Prof. Muhammad Younis Khan, Prof. Brig. Amir Ijaz, Prof. Tasneem Raza. In this course CPSP head office Karachi, Lahore, Islamabad, Multan, Faisalabad, Quetta, Peshawar and Hyderabad centers are linked via video. (PR)

Breastfeeding for more than six months
may protect against breast cancer

A new analysis has found that breastfeeding for more than six months may safeguard nonsmoking mothers against breast cancer. The same does not seem to hold true for smoking mothers, though. Published early online in the Journal of Clinical Nursing, the findings add to the list of benefits of breastfeeding for women and their babies.
To look at the relationship between breast cancer and certain aspects of pregnancy and breastfeeding, Emilio Gonz¡lez- PhD, of the University of Granada in Spain, and his colleagues analyzed the medical records of 504 female patients who were 19 to 91 years of age and who had been diagnosed and treated for breast cancer from 2004 to 2009 at the San Cecilio University Hospital in Granada. The team looked at factors including age of diagnosis, how long the women breastfed, family history of cancer, obesity, alcohol consumption, and smoking habits.
Their analysis revealed that women who underwent childbirth and who breastfed were diagnosed with breast cancer at a later age, regardless of the patients’ family history of cancer. Nonsmokers who breastfed for periods of longer than six months tended to be diagnosed with breast cancer much later in life—an average of 10 years later than nonsmokers who breastfed for a shorter period. In contrast, female smokers were diagnosed with breast cancer at a younger age and obtained no significant benefit from a longer period of breastfeeding.
“The results suggest that for nonsmokers, breastfeeding for more than six months not only provides children with numerous health benefits, but it also may protect mothers from breast cancer,” said Dr. Emilio Gonz¡lez. (PR)

Therapeutic delivery publishes special
focus issue on pulmonary drug delivery

With contributions from renowned scientists from industry and academia, Therapeutic Delivery, the international peer-reviewed monthly journal published by Future Science Ltd, has published a special focus issue dedicated to pulmonary drug delivery.Administration of therapeutic compounds via pulmonary delivery allows for higher local concentrations and the avoidance of side effects. However, the continuing rise in respiratory diseases worldwide has necessitated improvements in the pulmonary delivery route. Hence, this special issue focuses on the latest developments in pulmonary delivery of novel agents, inhalable dry powder technology and mechanisms of drug transport through the lung.
The special issue features a number of opinion-based pieces on topics including new approaches for early clinical development of pulmonary delivery products, strategies for the treatment of pulmonary fibrosis and overcoming undesirable properties of dry powder inhalers. In addition to the opinion pieces, there are a number of review and research articles, highlighting topics such as tuberculosis treatment, surfactant replacement therapies and the pulmonary delivery of liposomes.
An editorial piece by John McDermott and Alyson Connor highlights why a pulmonary delivery-focused issue is so important and timely: “Development of an inhaled product can be challenging since it relies upon a complex interplay between drug, formulation, device and patient. With current estimates of the cost to develop a new medicine now exceeding $1.5 billion, it is evident that new approaches are required to drive efficiency, minimize risk and maximize success.”
Peter Barnes, interviewed in the issue, discusses the recent progress towards effectively treating COPD and asthma. He explains how he first became involved in the field, his current research efforts, as well as offering words of advice to young scientists in respiratory diseases research.(PR)

© Professional Medical Publications. All rights reserved.